18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax

Journal of Nuclear Medicine

Volumn 44, Issue 4, 2003, Pages 540-548

  Demura, Yoshiki ^a   Tsuchida, Tatsuro ^a   Ishizaki, Takeshi ^a   Mizuno, Shiro ^a   Totani, Yoshitaka ^a   Ameshima, Shingo ^a   Miyamori, Isamu ^a   Sasaki, Masato ^a   Yonekura, Yoshiharu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

18F FDG PET; 201TI SPECT; Lung cancer; Nodal staging; Retention index

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THALLIUM 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM CHLORIDE;

ACCURACY; ARTICLE; BENIGN TUMOR; CALCULATION; CANCER CELL; CANCER DIAGNOSIS; CANCER STAGING; CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG ACCUMULATION; EVALUATION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; MEASUREMENT; MEDIASTINUM; METASTASIS; PATIENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD; THORAX CANCER; THORAX DISEASE; THORAX TUMOR; TIME; ADULT; AGED; CLASSIFICATION; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; LUNG TUMOR; MALE; MEDIASTINUM DISEASE; MEDIASTINUM TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MEDIASTINAL DISEASES; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0038315448     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Coleman RE. PET in lung cancer. J Nucl Med 1999;40:814-820.
2. 18F] fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg. 1998;85:1506-1511.
3. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150-185.
4. Nunan TO, Hain SF PET in oncology. 2 Other tumors. Nucl Med Commun 2000;21:229-223.
5. 18F]-FDG in oncology, a clinical update. Nucl Med Biol. 1996;23:717-735.
6. Kapucu LO, Meltzer CC, Townsend DW, et al. Fluorine-18-fluorodeoxyglucose uptake in pneumonia. J Nucl Med. 1998;39:1267-1269.
7. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994;35:1653-1655.
8. Jin MC, Jung-Gi I, Kyung-Hyun D, et al. Pulmonary tuberculoma evaluated by means of FDG-PET. findings in 10 cases Radiology. 2000;216:117-121.
9. Pitman AG, Hicks RJ, Kalff V, et al. Positron emission tomography in pulmonary masses where tissue diagnosis is unhelpful or not possible. Med J Aust. 2001; 175:303-307.
10. Sazon DA, Santiago SM, Soo Hoo GW, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med. 1996;153:417-421.
11. Chin BB, Zukerberg W, Buchpiguel C, et al. Thallium-201 uptake in lung cancer. J Nucl Med 1995;36:1514-1519.
12. Kohei Y, Okuyama A, Mori K, et al. Mediastinal lymph node metastasis from lung cancer: evaluation with T-201 SPECT - comparison with CT Radiology. 1994;192:813-817.
13. Takekawa H, Itoh K, Abe S, et al. Thallium-201 uptake, histopathological differentiation and Na-K ATPase in lung adenocarcinoma. J Nucl Med. 1996;37: 955-958.
14. 18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg. 1999;86:194-199.
15. Boemer AR, Weckesser M, Herzog H. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med. 1999;26:226-230
16. Kubota K, Itoh M, Ozaki K, et al Advantage of delayed whole-body FDG-PET imaging for tumor detection. Eur J Nucl Med. 2001;28:696-703.
17. 18F-FDG PET imaging for differentiating malignant from inflammatory processes J Nucl Med. 2001;42:1412-1417.
18. 18F-FDG PET for the evaluation of pulmonary nodules J Nucl Med. 2002;43:871-875.
19. Hamberg LM, Hunter GJ, Alpert NM, et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med. 1994; 35:1308-1312.
20. Liewarld F, Grosse S, Storck M, et al. How useful is positron emission tomography for lymph node staging in non-small-cell lung cancer? Thorac Cardiovasc Surg. 2000;48:93-96.
21. Younes M, Lechgo L, Somoano JR, et al Wide expression of the human erythrocyte glucose transporter Glut I in human cancers. Cancer Res. 1996;56 1164-1167.
22. 18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med. 1978;19:1154-1161.
23. 3H-2-deoxyglucose retention in murine tumor models. Nucl Med Biol. 1996;23:533-541.
24. Suzuki S, Toyota T, Suzuki H, et al. Partial purification from human mononuclear cells and placental plasma membranes of an insulin mediator which stimulates pyruvate dehydrogenase and suppresses glucose-6-phosphatase. Arch Biochem Biophys. 1984;235:418-426.
25. Gupta N, Gill H, Graeber G, et al Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest. 1998;114:1105-1111.
26. Higaslu K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human canser cells? in vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med. 1993;34:414-419.
27. Duhaylongsod FG, Lowe VJ, Patz EF, et al Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg. 1995;60:1348-1352.
28. Lowe VJ, Fletcher JW, Gobar L, et al Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075-1084.
29. Lowe VJ, Hoffman JM, Delong DM, et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med. 1994;35:1771-1776.
30. Larson SM. Cancer or inflammation? a holy grail for nuclear medicine. J Nucl Med. 1994;35:1647-1649.
31. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study J Nucl Med 1990;31: 1927-1933.
32. 201TI-SPECT in evaluation of pulmonary nodules. J Nucl Med. 2001;42:1489-1496.